Increased Release of Matrix Metalloproteinase-9 in Bronchoalveolar Lavage Fluid and by Alveolar Macrophages of Asthmatics

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 5, 1997, Pages 583-591

  Mautino, Gisèle ^a   Oliver, Nicolas ^a   Chanez, Pascal ^a   Bousquet, Jean ^a   Capony, Françoise ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; ENZYME INHIBITOR; GELATINASE B; PROTEIN KINASE C;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHOALVEOLAR LAVAGE; CELLS, CULTURED; COLLAGENASES; ENZYME INHIBITORS; HUMANS; MACROPHAGES, ALVEOLAR; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROTEIN KINASE C;

EID: 0031280307     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.5.2562     Document Type: Article

References (59)

1. Woessner, J., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145-2154.
2. Matrisian, L. M. 1992. The matrix-degrading metalloproteinases. Bioessays 14:455-463.
3. DiBattista, J. A., J. P. Pelletier, M. Zafarullah, N. Fujimoto, K. Obata, and J. Martel-Pelletier. 1995. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J. Rheumatol. Suppl. 43:123-128.
4. O'Connor, C. M., and M. X. FitzGerald. 1994. Matrix metalloproteases and lung disease. Thorax 49:602-609.
5. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-524.
6. Brewster, C. E., P. H. Howarth, R. Djukanovic, J. Wilson, S. T. Holgate, and W. R. Roche. 1990. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3:507-511.
7. Bousquet, J., P. Chanez, J. Y. Lacoste, R. White, P. Vic, P. Godard, and F. B. Michel. 1992. Asthma: a disease remodeling the airways. Allergy 47:3-11.
8. Bousquet, J., J. Lacoste, P. Chanez, P. Vic, P. Godard, and F. Michel. 1996. Bronchial elastic fibers in normal subjects and asthmatic patients. Am. J. Respir. Crit. Care Med. 153:1648-1654.
9. Welgus, H. G., E. J. Campbell, J. D. Cury, A. J. Eisen, R. M. Senior, S. M. Wilhelm, and G. I. Goldberg. 1990. Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86:1496-1502.
10. Shapiro, S. D. 1994. Elastolytic metalloproteinases produced by human mononuclear phagocytes: potential role in destructive lung disease. Am. J. Resp. Crit. Care Med. 150:S160-S164.
11. Shapiro, S. D., D. K. Kobayashi, A. P. Pentland, and H. G. Welgus. 1993. Induction of macrophage metalloproteinases by extracellular matrix: evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 268:8170-8175.
12. Lacraz, S., L. Nicod, B. Galve-de-Rochemonteix, C. Baumberger, J. M. Dayer, and H. G. Welgus. 1992. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90:382-388.
13. Wahl, L. M., and M. L. Corcoran. 1993. Regulation of monocyte/macrophage metalloproteinase production by cytokines. J. Periodontol. 64:467-473.
14. Hibbs, M. S., J. R. Hoidal, and A. H. Kang. 1987. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J. Clin. Invest. 80:1644-1650.
15. Welgus, H. G., R. M. Senior, W. C. Parks, A. J. Kahn, T. J. Ley, S. D. Shapiro, and F. J. Campbell. 1992. Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation. Matrix Suppl. 1:363-367.
16. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, and H. G. Welgus. 1990. Immune modulation of metalloproteinase production in human macrophages: selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest. 86:1204-1210.
17. Saarialho-Kere, U. K. H. G. Welgus, and W. C. Parks. 1990. Divergent mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem. 268:17354-17361.
18. Poston, R. N., P. Chanez, J. V. Lacoste, T. Litchfield, T. H. Lee, and J. Bousquet. 1992. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am. Rev. Respir. Dis. 145:918-921.
19. Godard, P., J. Chaintreuil, M. Damon, M. Coupe, O. Flandre, A. Crastesde-Paulet, and F. B. Michel. 1982. Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. J. Allergy Clin. Immunol. 70:88-93.
20. Rankin, J. A. 1989. The contribution of alveolar macrophages to hyperreactive airway disease. J. Allergy Clin. Immunol. 83:722-729.
21. Chanez, P., A. Vignola, N. Paul-Fugène, B. Dupas, P. Godard, F. Michel, and J. Bousquet. 1994. Modulation by IL-4 of cytokine release from mononuclear phagocytes in asthma. J. Allergy Clin. Immunol. 94:997-1005.
22. American Thoracic Society. 1995. Definitions, epidemiology, pathophysiology, diagnosis, and staging. In Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 152(Part 2):S79-S83.
23. Aas, K. 1981. Heterogeneity of bronchial asthma. Allergy 36:3-10.
24. Lacoste, J. Y., J. Bousquet, P. Chanez, T. Van-Vyve, J. Simony-Lafontaine, N. Lequeu, P. Vic, I. Enander, P. Godard, and F. B. Michel. 1993. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 92:537-548.
25. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
26. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267:515-519.
27. Xie, B., Z. Dong, and I. Fidler. 1994. Regulatory mechanisms for the expression of type IV collagenase/gelatinases in murine macrophages. J. Immunol. 152:3637-3644.
28. Kissane, J. M., and E. Robins. 1958. The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J. Biol. Chem. 233:184-189.
29. Woessner, J. F. 1995. Quantification of matrix metalloproteinases in tissue samples. Proteolytic enzymes: aspartic and metallopeptidases. Methods Enzymol. 248:510-528.
30. Hanemaaijer, R., P. Kolwijk, L. le Clerq, W. J. A. de Vree, and V. W. M. Van Hinsbergh. 1993. Regulation of matrix metalloproteinases in human vein and microvascular endothelial cells. Biochem. J. 296:803-809.
31. Fujimoto, N., N. Hosokawa, K. Iwata, Y. Okada, and T. Hayakawa. 1994. A one-step sandwich immunoassay for human matrix metalloproteinase using monclonal antibodies. Ann. N.Y. Acad. Sci. 737:359-361.
32. Van-Vyve, T., P. Chanez, A. Bernard, J. Bousquet, P. Godard, R. Lauwerijs, and Y. Sibille. 1995. Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjects. J. Allergy Clin. Immunol. 95:60-68.
33. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, and H. G. Welgus. 1991. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J. Immunol. 146:2724-2729.
34. Bentley, A. M. G. Menz, C. Storz, D. S. Robinson, B. Bradley, P. K. Jeffery, S. R. Durham, and A. B. Kay. 1992. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am. Rev. Respir. Dis. 146:500-506.
35. Poulter, L. W., G. Janossy, C. Power, S. Sreenan, and C. Burke. 1994. Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol. Today 15:258-261.
36. Joseph, M., A. B. Tonnel, G. Torpier, A. Capron, B. Arnoux, and J. Benveniste. 1983. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J. Clin. Invest. 71:221-230.
37. Fuller, R. W., G. O'Malley, A. J. Baker, and J. MacDermot. 1988. Human alveolar macrophage activation: inhibition by forskolin but not beta-adrenoceptor stimulation or phosphodiesterase inhibition. Pulm. Pharmacol. 1:101-106.
38. Borish, L., J. J. Mascali, J. Dishuck, W. R. Beam, R. J. Martin, and L. J. Rosenwasser. 1992. Detection of alveolar macrophage-derived IL-1 beta in asthma: inhibition with corticosteroids. J. Immunol. 149:3078-3082.
39. Chanez, P., M. Vignola, R. Steinger, P. Vic, F. Michel, and J. Bousquet. 1996. Platelet-derived growth factor in asthma. Allergy (In press)
40. Cluzel, M., M. Damon, P. Chanez, J. Bousquet, A. Crastes-de-Paulet, F. B. Michel, and P. Godard. 1987. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J. Allergy Clin. Immunol. 80:195-201.
41. Kelly, C., C. Ward, C. S. Stenton, G. Bird, D. J. Hendrick, and E. H. Walters. 1988. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. Thorax 43:684-692.
42. Birkedal-Hansen, H., W. G. Moore, M. K. Bodden, L. J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J. A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:197-250.
43. Stahle-Backdahl, M., B. D. Sudbeck, A. Z. Eisen, H. G. Welgus, and W. C. Parks. 1992. Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J. Invest. Dermatol. 99:497-503.
44. Elias, J. A., T. J. Ferro, M. D. Rossman, J. A. Greenberg, R. P. Daniele, A. D. Schreiber, and B. Freundlich. 1987. Differential prostaglandin production by unfractionated and density-fractionated human monocytes and alveolar macrophages. J. Leukoc. Biol. 42:114-121.
45. Ferro, T. J., J. A. Kern, J. A. Elias, M. Kamoun, R. P. Daniele, and M. D. Rossman. 1987. Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. Am. Rev. Respir. Dis. 135: 682-687.
46. Thurlbeck, W. M. 1990. Pathology of chronic airflow obstruction. Chest 97:6S-10S.
47. Cosio, M., H. Ghezzo, J. Hogg, R. Corhin, M. Loveland, J. Dossman, and P. Macklem. 1977. The relations between structural changes in small airways and pulmonary function tests. N. Engl. J. Med. 298:1277-1281.
48. Adesina, A. M., V. Vallyathan, E. N. McQuillen, S. O. Weaver, and J. E. Craighead. 1991. Bronchiolar inflammation and fibrosis associated with smoking: a morphologic cross-sectional population analysis. Am. Rev. Respir. Dis. 143:144-149.
49. Welgus, H., N. Connolly, and R. Senior. 1986. 12-o-tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases: high levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. J. Clin. Invest. 77:1675-1681.
50. Campbell, E. J., J. D. Cury, S. D. Shapiro, G. I. Goldberg, and H. G. Welgus. 1991. Neutral proteinases of human mononuclear phagocytes: cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol. 146:1286-1293.
51. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548-553.
52. O'Brian, C., and N. Ward. 1989. Biology of the protein kinase C family. Cancer Metastasis Rev. 8:199-203.
53. Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. 1984. Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleolide dependent protein kinase and protein kinase C. Biochemistry 23:5034-5041.
54. Delacourt, C., M. Le Bourgeois, M. D'Ortho, C. Doit, P. Schinmann, J. Navarro, A. Harf, J. Hartmann, and C. Lafuma. 1995. Imbalance between 95 kDa type IV collagenase and tissue inhibitor in sputum of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 152:765-774.
55. Murphy, G., M. I. Cockett, R. V. Ward, and A. J. P. Docherty. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 75 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277:277-279.
56. Senior, R. M., G. L. Griffin, C. J. Fliszar, S. D. Shapiro, G. I. Goldberg, and H. G. Welgus. 1991. Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266:7870-7875.
57. Senior, R. M., N. L. Connolly, J. D. Cury, H. G. Welgus, and E. J. Campbell. 1989. Elastin degradation by human alveolar macrophages: a prominent role of metalloproteinase activity. Am. Rev. Respir. Dis. 139:1251-1256.
58. Azzam, H. S., G. Arand, M. E. Lippman, and W. E. Thompson. 1993. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst. 85:1758-1764.
59. Peppin, G. J., and S. J. Weiss. 1986. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl. Acad. Sci. USA 83:4322-4326.